Danaher Corporation (VIE:DHRC)

Market Cap	133.80B -21.2%
Revenue (ttm)	20.92B +2.9%
Net Income	3.08B -7.3%
EPS	4.30 -4.5%
Shares Out	n/a
PE Ratio	43.47
Forward PE	26.22
Dividend	1.12 (0.60%)
Ex-Dividend Date	Dec 26, 2025

Volume	n/a
Average Volume	1
Open	183.22
Previous Close	186.26
Day's Range	182.48 - 184.72
52-Week Range	153.52 - 217.30
Beta	n/a
RSI	33.38
Earnings Date	Jan 28, 2026

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for man...

• Industry: Laboratory Analytical Instruments
• Founded: 1969
• Employees: 60,000
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: DHRC

Financial Performance

In 2025, Danaher's revenue was $24.57 billion, an increase of 2.90% compared to the previous year's $23.88 billion. Earnings were $3.61 billion, a decrease of -7.31%.

Financial numbers in USD